[CH3:1][N:2]1[CH2:7][CH2:6][CH2:5][C:4]([NH2:14])([C:8]2[CH:13]=[CH:12][CH:11]=[CH:10][CH:9]=2)[CH2:3]1.C(N(C(C)C)C(C)C)C.[CH3:24][O:25][C:26]1[CH:34]=[C:33]([C:35]([F:38])([F:37])[F:36])[CH:32]=[C:31]([C:39]([F:42])([F:41])[F:40])[C:27]=1[C:28](Cl)=[O:29]>ClCCl>[CH3:24][O:25][C:26]1[CH:34]=[C:33]([C:35]([F:36])([F:37])[F:38])[CH:32]=[C:31]([C:39]([F:40])([F:41])[F:42])[C:27]=1[C:28]([NH:14][C:4]1([C:8]2[CH:13]=[CH:12][CH:11]=[CH:10][CH:9]=2)[CH2:5][CH2:6][CH2:7][N:2]([CH3:1])[CH2:3]1)=[O:29]To a solution of 205 mg (1.077 mmol) rac-1-methyl-3-phenyl-piperidin-3-ylamine (Example A.1) and 369 ul (2.154 mmol) N-ethyldiisopropylamine in dichloromethane (2.5 ml) was added dropwise a solution of 430 mg (1.4 mmol) 2-methoxy-4,6-bis-trifluoromethyl-benzoyl chloride (CAS: 886503-47-5) in dichloromethane (2.0 ml) at room temperature. The mixture was stirred at room temperature for 16 hours. The solvent was removed in vacuo. The crude product was purified on silica gel (Eluent: Heptane/ethyl acetate 0 to 100%) to provide 340 mg (69%) of the title compound as a light yellow foam. MS (m/e): MS (m/e): 461.4 (M+H).